PL2091938T3 - Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2 - Google Patents

Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2

Info

Publication number: PL2091938T3
Authority: PL; Poland
Prior art keywords: piperidinylamino; pyridazines; receptor antagonists; fast dissociating; dissociating dopamine
Prior art date: 2006-12-08

Application number

PL07847833T

Other languages

English (en)

Inventor

Gregor James Macdonald

José Ignacio Andrés-Gil

Den Keybus Frans Alfons Maria Van

José Manuel Bartolomé-Nebreda

Gool Michiel Luc Maria Van

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-08

Filing date

2007-12-05

Publication date

2011-04-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37964744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2091938(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-12-05 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2011-04-29 Publication of PL2091938T3 publication Critical patent/PL2091938T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

PL07847833T 2006-12-08 2007-12-05 Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2 PL2091938T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06125685		2006-12-08
EP07847833A EP2091938B1 (en)	2006-12-08	2007-12-05	Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
PCT/EP2007/063338 WO2008068277A1 (en)	2006-12-08	2007-12-05	Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists

Publications (1)

Publication Number	Publication Date
PL2091938T3 true PL2091938T3 (pl)	2011-04-29

Family

ID=37964744

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07847833T PL2091938T3 (pl)	2006-12-08	2007-12-05	Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2

Country Status (28)

Country	Link
US (1)	US8466153B2 (pl)
EP (1)	EP2091938B1 (pl)
JP (1)	JP5255568B2 (pl)
KR (1)	KR101468384B1 (pl)
CN (1)	CN101547915B (pl)
AR (1)	AR064198A1 (pl)
AT (1)	ATE486070T1 (pl)
AU (1)	AU2007328897B2 (pl)
BR (1)	BRPI0720247A2 (pl)
CA (1)	CA2665924C (pl)
CL (1)	CL2007003556A1 (pl)
CY (1)	CY1112227T1 (pl)
DE (1)	DE602007010179D1 (pl)
DK (1)	DK2091938T3 (pl)
EA (1)	EA016654B1 (pl)
ES (1)	ES2354756T3 (pl)
IL (1)	IL199076A (pl)
JO (1)	JO2642B1 (pl)
MX (1)	MX2009005983A (pl)
MY (1)	MY148772A (pl)
NO (1)	NO20092574L (pl)
NZ (1)	NZ576484A (pl)
PL (1)	PL2091938T3 (pl)
PT (1)	PT2091938E (pl)
SI (1)	SI2091938T1 (pl)
TW (1)	TWI433676B (pl)
UA (1)	UA98940C2 (pl)
WO (1)	WO2008068277A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2769B1 (en)	2005-10-26	2014-03-15	جانسين فارماسوتيكا ان. في	Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2849B1 (en) *	2007-02-13	2015-03-15	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011414A (es) *	2007-04-23	2009-11-05	Janssen Pharmaceutica Nv	Derivados de piridina como antagonistas del receptor de dopamina 2 de disociacion rapida.
ES2400710T3 (es) *	2007-04-23	2013-04-11	Janssen Pharmaceutica, N.V.	Tia(dia)zoles como antagonistas del receptor de dopamina 2 de disociación rápida
SI2148873T1 (sl) *	2007-04-23	2013-01-31	Janssen Pharmaceutica, N.V.	Derivati 4-alkoksipiridazina kot antagonisti receptorja dopamina 2 s hitro disociacijo
BRPI0915834A2 (pt) *	2008-07-03	2015-11-03	Janssen Pharmaceutica Nv	6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6
DK2307374T3 (en) *	2008-07-31	2017-05-01	Janssen Pharmaceutica Nv	PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS
EP4574152A1 (en) *	2023-12-22	2025-06-25	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Potassium channel activators for use in the treatment of epileptic disorders

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2341965C3 (de) *	1973-08-20	1979-01-25	C.H. Boehringer Sohn, 6507 Ingelheim	4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen
NO147672C (no)	1975-09-23	1983-05-25	Janssen Pharmaceutica Nv	Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
US4197304A (en) *	1975-09-23	1980-04-08	Janssen Pharmaceutica N.V.	N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
EG12406A (en) *	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
DE3218482A1 (de)	1982-05-15	1983-11-17	Bayer Ag, 5090 Leverkusen	Substituierte 5-trifluormethyl-1,3,4-thiadiazol-2-yloxyessigsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
MX173362B (es)	1987-03-02	1994-02-23	Pfizer	Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
GB9216298D0 (en)	1991-08-15	1992-09-16	Ici Plc	Piperidine derivatives
TW406075B (en)	1994-12-13	2000-09-21	Upjohn Co	Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
US5753679A (en)	1995-05-10	1998-05-19	Hoffmann-La Roche Inc.	Benzyl-piperidine derivatives
MY116093A (en) *	1996-02-26	2003-11-28	Upjohn Co	Azolyl piperazinyl phenyl oxazolidinone antimicrobials
TW504510B (en) *	1996-05-10	2002-10-01	Janssen Pharmaceutica Nv	2,4-diaminopyrimidine derivatives
WO1999009025A2 (en)	1997-08-15	1999-02-25	Pfizer Products Inc.	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
KR100261139B1 (ko)	1998-01-16	2000-08-01	황준수	신규한 알릴티오피리다진 유도체 및 그의 제조방법
AR028948A1 (es)	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
HUP0303258A3 (en)	2001-02-23	2004-06-28	Merck & Co Inc	N-substituted nonaryl-heterocyclic nmda/nr2b antagonists and pharmaceutical compositions containing them
DK1443046T3 (da)	2001-10-09	2009-04-14	Kyorin Seiyaku Kk	Nye 4-(2-furoyl)-amino-piperidiner, mellemprodukter til deres syntese, fremgangsmåde til deres fremstilling og deres medicinske anvendelse
WO2003049736A1 (en)	2001-12-11	2003-06-19	Sepracor, Inc.	4-substituted piperidines, and methods of use thereof
WO2003062215A1 (en)	2002-01-25	2003-07-31	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
JP4607458B2 (ja)	2002-02-05	2011-01-05	ハイ・ポイント・ファーマスーティカルズ、エルエルシー	新規なアリールおよびへテロアリールピペラジン
WO2003072554A1 (en)	2002-02-28	2003-09-04	Takeda Chemical Industries, Ltd.	Azole compounds
SE0201544D0 (sv)	2002-05-17	2002-05-17	Biovitrum Ab	Novel compounds and thier use
AU2003272892A1 (en) *	2002-09-26	2004-04-19	Mandom Corporation	Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
CA2524498C (en)	2003-05-08	2012-01-24	Kyorin Pharmaceutical Co., Ltd.	4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
WO2005005779A2 (en)	2003-07-14	2005-01-20	Genesis Mining Technologies (Pty) Ltd	Dual retention cutting arrangement
WO2005009976A1 (en)	2003-07-29	2005-02-03	Novo Nordisk A/S	Pyridazinyl- piperazines and their use as histamine h3 receptor ligands
EP1653969A4 (en)	2003-08-07	2006-12-20	Japan Tobacco Inc	PYRROLO 1,2-B PYRIDAZINE DERIVATIVES
MXPA06012510A (es)	2004-04-28	2006-12-15	Pfizer	Derivados de 3-heterociclil-4-fenil-triazol como inhibidores del receptor de vasopresina via.
JP2008501031A (ja)	2004-05-28	2008-01-17	バーテックス　ファーマシューティカルズ　インコーポレイテッド	ムスカリン受容体のモジュレーター
AR051092A1 (es)	2004-09-20	2006-12-20	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
MX2007005205A (es)	2004-10-29	2007-05-11	Kalypsys Inc	Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma.
DE602006010870D1 (de)	2005-06-20	2010-01-14	Schering Corp	Als antagonisten von histamin h3 geeignete piperidinderivate
JO2769B1 (en)	2005-10-26	2014-03-15	جانسين فارماسوتيكا ان. في	Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
WO2007130383A2 (en)	2006-04-28	2007-11-15	Northwestern University	Compositions and treatments using pyridazine compounds and secretases
CA2658960A1 (en)	2006-08-15	2008-02-21	Alfred Binggeli	Phenyl, pyridine and quinoline derivatives
CA2606658A1 (en) *	2006-10-13	2008-04-13	Mike Tyers	Compositions and methods for treating neurological disorders or damage
JO2849B1 (en)	2007-02-13	2015-03-15	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
DK2307374T3 (en) *	2008-07-31	2017-05-01	Janssen Pharmaceutica Nv	PIPERAZIN-1-YLTRIFLUORMETHYL-SUBSTITUTED PYRIDINES AS QUICK DISSOCATING DOPAMIN-2 RECEPTOR ANTAGONISTS

2007
- 2007-11-19 JO JO2007479A patent/JO2642B1/en active
- 2007-12-05 PL PL07847833T patent/PL2091938T3/pl unknown
- 2007-12-05 AT AT07847833T patent/ATE486070T1/de active
- 2007-12-05 CA CA2665924A patent/CA2665924C/en active Active
- 2007-12-05 AU AU2007328897A patent/AU2007328897B2/en not_active Ceased
- 2007-12-05 UA UAA200903503A patent/UA98940C2/ru unknown
- 2007-12-05 BR BRPI0720247-4A patent/BRPI0720247A2/pt active Search and Examination
- 2007-12-05 CN CN2007800446538A patent/CN101547915B/zh active Active
- 2007-12-05 SI SI200730472T patent/SI2091938T1/sl unknown
- 2007-12-05 EA EA200970553A patent/EA016654B1/ru not_active IP Right Cessation
- 2007-12-05 EP EP07847833A patent/EP2091938B1/en active Active
- 2007-12-05 MY MYPI20092235A patent/MY148772A/en unknown
- 2007-12-05 WO PCT/EP2007/063338 patent/WO2008068277A1/en active Application Filing
- 2007-12-05 MX MX2009005983A patent/MX2009005983A/es active IP Right Grant
- 2007-12-05 ES ES07847833T patent/ES2354756T3/es active Active
- 2007-12-05 DE DE602007010179T patent/DE602007010179D1/de active Active
- 2007-12-05 JP JP2009539743A patent/JP5255568B2/ja active Active
- 2007-12-05 NZ NZ576484A patent/NZ576484A/en not_active IP Right Cessation
- 2007-12-05 DK DK07847833.6T patent/DK2091938T3/da active
- 2007-12-05 KR KR1020097010872A patent/KR101468384B1/ko not_active Expired - Fee Related
- 2007-12-05 US US12/516,645 patent/US8466153B2/en active Active
- 2007-12-05 PT PT07847833T patent/PT2091938E/pt unknown
- 2007-12-07 AR ARP070105498A patent/AR064198A1/es unknown
- 2007-12-07 CL CL200703556A patent/CL2007003556A1/es unknown
- 2007-12-07 TW TW096146645A patent/TWI433676B/zh not_active IP Right Cessation
2009
- 2009-06-02 IL IL199076A patent/IL199076A/en active IP Right Grant
- 2009-07-07 NO NO20092574A patent/NO20092574L/no not_active Application Discontinuation
2011
- 2011-01-27 CY CY20111100088T patent/CY1112227T1/el unknown

Also Published As

Publication number	Publication date
UA98940C2 (ru)	2012-07-10
HK1137434A1 (en)	2010-07-30
JO2642B1 (en)	2012-06-17
CN101547915B (zh)	2013-08-21
US8466153B2 (en)	2013-06-18
CY1112227T1 (el)	2015-12-09
BRPI0720247A2 (pt)	2013-12-31
EA200970553A1 (ru)	2009-10-30
NZ576484A (en)	2010-10-29
AR064198A1 (es)	2009-03-18
IL199076A (en)	2012-12-31
US20100076187A1 (en)	2010-03-25
CN101547915A (zh)	2009-09-30
ES2354756T3 (es)	2011-03-17
EP2091938A1 (en)	2009-08-26
CL2007003556A1 (es)	2008-06-13
SI2091938T1 (sl)	2011-02-28
KR101468384B1 (ko)	2014-12-03
CA2665924C (en)	2014-08-12
DK2091938T3 (da)	2011-02-07
CA2665924A1 (en)	2008-06-12
WO2008068277A1 (en)	2008-06-12
JP2010511673A (ja)	2010-04-15
AU2007328897B2 (en)	2013-01-10
NO20092574L (no)	2009-09-08
JP5255568B2 (ja)	2013-08-07
ATE486070T1 (de)	2010-11-15
AU2007328897A1 (en)	2008-06-12
EP2091938B1 (en)	2010-10-27
PT2091938E (pt)	2011-01-20
MY148772A (en)	2013-05-31
KR20090089858A (ko)	2009-08-24
TW200831098A (en)	2008-08-01
TWI433676B (zh)	2014-04-11
EA016654B1 (ru)	2012-06-29
DE602007010179D1 (de)	2010-12-09
MX2009005983A (es)	2009-06-16

Publication	Publication Date	Title
AP2607A (en)	2013-03-05	Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
IL200310A0 (en)	2010-04-29	Fast dissociating dopamine 2 receptor antagonists
IL210834A0 (en)	2011-04-28	Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists
IL202752A0 (en)	2011-08-01	Il-23 receptor antagonists and uses thereof
IL229507A0 (en)	2013-12-31	Extrinsic opioid receptor antagonists and their uses
PL2137191T3 (pl)	2016-12-30	Antagoniści obwodowego receptora opioidowego i ich zastosowania
GB0611154D0 (en)	2006-07-19	Novel receptor antagonists and their methods of use
HRP20150661T1 (en)	2015-09-25	Peripheral opioid receptor and antagonists and uses thereof
IL201663A0 (en)	2010-05-31	4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
IL187426A0 (en)	2008-02-09	Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
IL195972A0 (en)	2009-09-01	Cinnamoyl-piperazine derivatives and their use as par-i antagonists
PL2091938T3 (pl)	2011-04-29	Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2
SI2307374T1 (sl)	2017-05-31	Piperazin-1-il-trifluorometil-substituirani-piridini kot hitro disociirajoči antagonisti receptorja dopamin 2
IL205949A0 (en)	2010-11-30	3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
IL201661A0 (en)	2010-05-31	Thia(dia) zoles as fast dissociating dopamine 2 receptor antagonists
IL201662A0 (en)	2010-05-31	Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
ZA200810629B (en)	2010-02-24	Phenylpentadienoyl derivatives and their use as par 1 antagonists
GB0604234D0 (en)	2006-04-12	Novel receptor antagonists and their methods of use
GB0611155D0 (en)	2006-07-19	Novel receptor antagonists and their methods of use
GB0611157D0 (en)	2006-07-19	Novel receptor antagonists and their methods of use